Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook-square
x
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
Medicine Availability
Support

Home > About Us > Legislation > SROs > Promotion and Growth of Active Pharmaceutical Ingredient (API) Industry in Pakistan

Promotion and Growth of Active Pharmaceutical Ingredient (API) Industry in Pakistan

Asad Ullah SROs March 15, 2022May 19, 2022

Notification No. F. 1-2/2022 -CEO-DRAP, dated 2nd March, 2022.

API-promotion-policy-DRAP-2032022 Download

Share this:

LinkedIn
WhatsApp
Facebook
X

← SRO 406(I)/2022 (Reduction in MRP of Remdesivir 100mg injection)
Drug Product Recall: Sodium Chloride 0.9% INFUSION (Batch#A060E21) by M/s. Otsuka Pakistan Limited, Hub. →

DRAP at a Glance
Organization
Legislation
- Acts
- Rules
- Regulations
- SROs
- Notifications
Boards and Committees
Quality Management System
- Quality Policy
- Management Reviews

Quick Navigation

Quick Navigation

Registered Drugs Index
Drug Pricing Index
List of Pharmaceutical Units

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem